Early recognition of ailments is essential for improving patient outcomes and reducing the impact of chronic conditions. Traditionally, disease assessment has relied on symptomatic observations and conventional https://alyshaziin425319.blog-gold.com/39927828/investigating-novel-biomarkers-for-early-disease-detection